Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes (Q60045997)
Jump to navigation
Jump to search
scientific article published on 07 December 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes |
scientific article published on 07 December 2018 |
Statements
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes (English)
Jessica W Skelley
Brooke S Carter
7 December 2018
10 references
13 March 2019
14 March 2019
24 March 2019
17 June 2019
2 October 2019
18 November 2019
30 January 2021
4 February 2021
24 August 2022
10 references
13 March 2019
14 March 2019
24 March 2019
17 June 2019
2 October 2019
18 November 2019
30 January 2021
4 February 2021
24 August 2022
9 references
13 March 2019
14 March 2019
24 March 2019
17 June 2019
2 October 2019
18 November 2019
30 January 2021
4 February 2021
24 August 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference